BPGAM
SGYP

BTG Pactual Global Asset Management’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

BTG Pactual Global Asset Management’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-34,172
Closed -$154K – 167
2013
Q3 		$154K Sell
34,172
-16,528
-33% -$74.1K 0.03% 98
2013
Q2 		$216K Buy
+50,700
New +$255K 0.06% 94

Other funds holding SGYP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

BTG Pactual Global Asset Management's SGYP Position: Q4 2013 in Review

BTG Pactual Global Asset Management sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2013, closing a stake of 34,172 shares — an estimated $154K sold.

BTG Pactual Global Asset Management first reported a position in SGYP in Q2 2013 and held it in 2 quarters. The position peaked at $216K in Q2 2013. 72 funds tracked by Wall St. Rank hold SGYP as of Q4 2013.

  • BTG Pactual Global Asset Management reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2013 after selling out during the quarter.
  • BTG Pactual Global Asset Management sold 34,172 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2013, an estimated $154K.
  • BTG Pactual Global Asset Management first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 2 quarters.
  • BTG Pactual Global Asset Management's Synergy Pharmaceuticals, Inc Common Stock position peaked at $216K in Q2 2013.
  • 72 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2013.

Based on BTG Pactual Global Asset Management's 13F filing for Q4 2013, filed 10 Feb 2014.